Release date: 2007-07-25
High-quality domestic interventional device cost-effective Minimally invasive interventional therapy for cardiovascular disease has won the favor of many patients because of its small trauma, reliable efficacy, less complications, no blood transfusion, short hospital stay, and repeated repetitions. However, the expensive cost of an imported stent of tens of thousands of dollars often makes many domestic patients look sigh. Recently, a large-scale clinical trial has shown that high-quality domestic cardiac interventional devices are cost-effective and the results are equally reassuring.
Since June last year, a new domestic biodegradable coating coronary stent has been established by more than 50 hospitals in more than 20 provinces, led by the Department of Cardiology, General Hospital of Shenyang Military Region, to treat large-scale, multi-center coronary heart disease. Registered transnational clinical studies (3 foreign heart centers in Indonesia, Malaysia and Thailand participated in the study). In this study, 2077 patients with coronary heart disease were treated with this new domestic biodegradable coating drug-eluting stent. After half a year of follow-up, the stent can reduce the restenosis after interventional therapy and reduce the stent thrombosis. The effective rate is over 98%. Compared with the imported bracket, the effect is almost the same, but it is about 40% cheaper than the imported bracket. The results of this research have been recognized by international peers, and the reputation of quality domestically produced stents has been greatly improved.
According to authoritative statistics, there are 150,000 children with congenital heart disease in 1.2 million birth defects per year in China. Professor Zhu Xianyang of the Department of Congenital Heart Disease said that due to factors such as improper medication during pregnancy, viral infection, rubella, family genetics, food contamination and environmental impact, the incidence of congenital heart disease in children in Liaoning is on the rise, with thousands of children. Eighth. Children with congenital heart disease should be treated early and treated early, and the effective cure rate through interventional surgery is 98.5%.
Similarly, in the past few years, imported occluders were expensive, and many children did not get early corrections and entered adulthood. They even lost their chances of surgery and prematurely confessed to others.
In 2002, the domestic use of ventricular occlusion devices, atrial occlusion devices, and patent ductus arteriosus closures have broken the occluder completely dependent on imports, and the price is 60% of imported occluders. The hospital's clinical department of congenital heart disease uses more than 3,000 domestic occluders and a success rate of 98.8%. The domestic occluder is reliable and the quality is not inferior to imported products. The large number of clinical use of domestic occluders has ridden thousands of domestic patients from the pain of suffering and restore the lives of normal people. ——Shanghai Medical Device Industry Association
Organic Red Wolfberry,Dried Red Wolfberry,Goji Berry Ningxia Wolfberry,Red Color Dried Goji Berry
NINGXIA STARLIGHT FOOD TRADE CO.,LTD , https://www.starlightfood.com